Importantly, we demonstrated that the combination of chemotherapy drugs with inhibitors of WAT browning or FFAs uptake resulted in improved anti-cancer efficacy, presenting a novel therapeutic approach for treating CRC with abnormal MIIP expression. The gene discussed is MIIP; the disease is colorectal carcinoma.